|
|
|
|
|
|
|
Fig. 8
The cost of clinical pathology service provided by the Zeneca laboratory
compared to 23 contract laboratories costing an identical Phase II trial. The
contract laboratories are identified by letter and (UK) indicates the laboratory
was based in the United Kingdom rather than mainland Europe. |
|
|
|
|
|
|
|
|
VIII. Direct Cost and Indirect Cost Benefits |
|
|
|
|
|
|
|
|
Although it may be inconvenient for the sponsor's Accounts Department to have to deal with multiple local laboratories, the direct cost is usually significantly less than had the analysis been performed at a central laboratory. The up front costs are also significantly greater with a central laboratory but it must be recognized that only between 2530% is allocated against the analytical cost. The residual direct cost goes to cover additional services, some of which are listed in the following: |
|
|
|
|
|